X
19
Halozyme Therapeutics, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is HYALURONIDASE RECOMBINANT HUMAN, with a corresponding application number 21859 and regulatory information .
proudly manufactured in the
Halozyme Therapeutics's HYLENEX RECOMBINANT INJECTABLE;INJECTION, medication with 150 UNITS/ML of HYALURONIDASE RECOMBINANT HUMAN.